A transient ischaemic attack, TIA, or mini-stroke, is the same as a stroke, but the symptoms last a short time. A TIA is a warning that you are at risk of having a stroke.
A transient ischaemic attack or TIA (also known as a mini-stroke) is a major warning sign of a stroke. This guide explains what you can do to reduce your risk of a stroke.
Our round-table meetings aim to share knowledge arising from our funded research and create debate about the implications for health and social care policy and practice.
Most stroke and transient ischaemic attack (TIA) survivors are asked to take medicines, which some can find difficult. However, taking the medicines prescribed after a stroke, or TIA, and following lifestyle advice can reduce the chance of another stroke by 80%. Unfortunately, over 25% of stroke survivors do not continue these medicines, even for the first year after their stroke. Another 20% take less than is needed for the medicines to work.
This research will use the views of stroke and TIA survivors to design a life-long medicines support service which could be provided by pharmacists.
People who have survived a previous stroke or transient ischaemic attack (TIA) are at particularly high risk of subsequent, ‘recurrent’ stroke with 30% having another stroke in the following five years. High blood pressure is the most important reversible risk factor for having a recurrent stroke. The aim of this study is to develop and test a self-monitoring system of high blood pressure, tailored to the needs of stroke and TIA survivors, which will include self-adjustment of medication where possible in consultation with a GP.
Universty of Oxford News Release:Immediate aspirin after mini-stroke substantially reduces risk of major stroke
This research is focused on assessing the relationship between the variability of the blood flow through the blood vessels supplying the brain, and the risk of stroke in patients who have already had a stroke or “mini-stroke” (TIA) in the past.
This fellowship aims to develop, tailor and target the delivery of a 6-week group intervention that offers educational, psychological and social support for people following TIA and minor stroke.
This study is investigating whether colchicine, a medication used to treat gout, could help to stop people who have previously had a stroke or TIA from having further strokes.